Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-27 4:05 pm Purchase | 2024-12-18 | 13G | ALX Oncology Holdings Inc. ALXO | HBM Healthcare Investments (Cayman) Ltd. | 3,426,929 6.500% | 3,426,929 (New Position) | Filing History |
| 2024-12-06 11:33 am Sale | 2024-11-29 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 1,798,875 3.400% | -4,066,231 (-69.33%) | Filing History |
| 2024-11-14 7:22 pm Sale | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 0 0.000% | -2,255,000 (Position Closed) | Filing History |
| 2024-11-14 6:58 pm Purchase | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | Vivo Capital Fund IX L.P. | 1,813,864 3.400% | 1,813,864 (New Position) | Filing History |
| 2024-11-14 3:02 pm Sale | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | Cormorant Asset Management LP | 0 0.000% | -3,142,079 (Position Closed) | Filing History |
| 2024-11-12 09:50 am Sale | 2024-11-08 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 5,865,106 11.135% | -1,607,715 (-21.51%) | Filing History |
| 2024-10-10 4:14 pm Sale | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | Integrated Core Strategies (US) LLC | 2,002,374 3.800% | -959,297 (-32.39%) | Filing History |
| 2024-08-22 4:00 pm Purchase | 2024-08-12 | 13G | ALX Oncology Holdings Inc. ALXO | TANG CAPITAL PARTNERS LP | 4,040,800 7.700% | 4,040,800 (New Position) | Filing History |
| 2024-08-13 4:17 pm Purchase | 2024-08-06 | 13G | ALX Oncology Holdings Inc. ALXO | Integrated Core Strategies (US) LLC | 2,961,671 5.600% | 2,961,671 (New Position) | Filing History |
| 2024-02-14 7:45 pm Sale | 2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 2,255,000 4.500% | -11,000 (-0.49%) | Filing History |
| 2024-02-14 7:28 pm Sale | 2023-12-15 | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 2,949,580 5.900% | -1,259,395 (-29.92%) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group LLC | 4,909,264 9.600% | -82,281 (-1.65%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 7,472,821 14.999% | 1,359,393 (+22.24%) | Filing History |
| 2023-12-19 5:38 pm Sale | 2023-12-13 | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 4,208,975 8.400% | -512,015 (-10.85%) | Filing History |
| 2023-10-16 5:15 pm Purchase | 2023-10-04 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group LLC | 4,991,545 9.600% | 4,991,545 (New Position) | Filing History |
| 2023-10-13 4:00 pm Purchase | 2023-10-03 | 13G | ALX Oncology Holdings Inc. ALXO | Cormorant Asset Management LP | 3,142,079 6.310% | 3,142,079 (New Position) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.600% | 2,266,000 (New Position) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 6,113,428 15.000% | 1,832,912 (+42.82%) | Filing History |
| 2022-08-10 08:10 am Purchase | 2022-08-09 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 4,280,516 10.522% | 1,687,577 (+65.08%) | Filing History |
| 2022-06-10 10:14 am Sale | 2022-05-31 | 13G | ALX Oncology Holdings Inc. ALXO | Wellington Management Group LLP | 1,128,101 2.770% | -2,600,229 (-69.74%) | Filing History |